Because clinical-pathological correlations are imperfect, biomarkers, which can detect abnormal TDP-43 aggregates in vivo, are needed to provide an early etiological diagnosis (i.e., ALS caused due to abnormal TDP-43 vs. FUS or tau aggregates in FTD). The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.